BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23758647)

  • 1. Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline - the Sydney Memory and Aging Study.
    Fuchs T; Trollor JN; Crawford J; Brown DA; Baune BT; Samaras K; Campbell L; Breit SN; Brodaty H; Sachdev P; Smith E
    Aging Cell; 2013 Oct; 12(5):882-9. PubMed ID: 23758647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage inhibitory cytokine-1/growth differentiation factor 15 as a marker of cognitive ageing and dementia.
    Jiang J; Wen W; Sachdev PS
    Curr Opin Psychiatry; 2016 Mar; 29(2):181-6. PubMed ID: 26731555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inverse relationship between serum macrophage inhibitory cytokine-1 levels and brain white matter integrity in community-dwelling older individuals.
    Jiang J; Trollor JN; Brown DA; Crawford JD; Thalamuthu A; Smith E; Breit SN; Liu T; Brodaty H; Baune BT; Sachdev PS; Wen W
    Psychoneuroendocrinology; 2015 Dec; 62():80-8. PubMed ID: 26254771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease.
    Breit SN; Carrero JJ; Tsai VW; Yagoutifam N; Luo W; Kuffner T; Bauskin AR; Wu L; Jiang L; Barany P; Heimburger O; Murikami MA; Apple FS; Marquis CP; Macia L; Lin S; Sainsbury A; Herzog H; Law M; Stenvinkel P; Brown DA
    Nephrol Dial Transplant; 2012 Jan; 27(1):70-5. PubMed ID: 21940482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric symptoms in older people with and without cognitive impairment.
    Brodaty H; Heffernan M; Draper B; Reppermund S; Kochan NA; Slavin MJ; Trollor JN; Sachdev PS
    J Alzheimers Dis; 2012; 31(2):411-20. PubMed ID: 22571979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of serum macrophage inhibitory cytokine-1 levels with gray matter volumes in community-dwelling older individuals.
    Jiang J; Wen W; Brown DA; Crawford J; Thalamuthu A; Smith E; Breit SN; Liu T; Zhu W; Brodaty H; Baune BT; Trollor JN; Sachdev PS
    PLoS One; 2015; 10(4):e0123399. PubMed ID: 25867953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
    O'Neill RS; Emmanuel S; Williams D; Stoita A
    World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism.
    Breit SN; Johnen H; Cook AD; Tsai VW; Mohammad MG; Kuffner T; Zhang HP; Marquis CP; Jiang L; Lockwood G; Lee-Ng M; Husaini Y; Wu L; Hamilton JA; Brown DA
    Growth Factors; 2011 Oct; 29(5):187-95. PubMed ID: 21831009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
    Rozzini L; Chilovi BV; Bertoletti E; Conti M; Del Rio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):550-5. PubMed ID: 16642542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage inhibitory cytokine-1/growth differentiation factor-15 as a predictor of colonic neoplasia.
    Danta M; Barber DA; Zhang HP; Lee-Ng M; Baumgart SWL; Tsai VWW; Husaini Y; Saxena M; Marquis CP; Errington W; Kerr S; Breit SN; Brown DA
    Aliment Pharmacol Ther; 2017 Aug; 46(3):347-354. PubMed ID: 28569401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive patterns in relation to biomarkers of cerebrovascular disease and vascular risk factors.
    Miralbell J; López-Cancio E; López-Oloriz J; Arenillas JF; Barrios M; Soriano-Raya JJ; Galán A; Cáceres C; Alzamora M; Pera G; Toran P; Dávalos A; Mataró M
    Cerebrovasc Dis; 2013; 36(2):98-105. PubMed ID: 24029412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic markers of inflammation and cognitive decline in old age.
    Schram MT; Euser SM; de Craen AJ; Witteman JC; Frölich M; Hofman A; Jolles J; Breteler MM; Westendorp RG
    J Am Geriatr Soc; 2007 May; 55(5):708-16. PubMed ID: 17493190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic inflammation is associated with MCI and its subtypes: the Sydney Memory and Aging Study.
    Trollor JN; Smith E; Baune BT; Kochan NA; Campbell L; Samaras K; Crawford J; Brodaty H; Sachdev P
    Dement Geriatr Cogn Disord; 2010; 30(6):569-78. PubMed ID: 21252552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First Behavioural Characterisation of a Knockout Mouse Model for the Transforming Growth Factor (TGF)-β Superfamily Cytokine, MIC-1/GDF15.
    Low JK; Ambikairajah A; Shang K; Brown DA; Tsai VW; Breit SN; Karl T
    PLoS One; 2017; 12(1):e0168416. PubMed ID: 28081177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal relationship between depressive symptoms and cognitive impairment: the Italian Longitudinal Study on Aging.
    Panza F; D'Introno A; Colacicco AM; Capurso C; Del Parigi A; Caselli RJ; Frisardi V; Scapicchio P; Chiloiro R; Scafato E; Gandin C; Vendemiale G; Capurso A; Solfrizzi V
    J Alzheimers Dis; 2009; 17(4):899-911. PubMed ID: 19542612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of the genes encoding CD40 and growth differentiation factor 15 and in the 9p21.3 region in patients with rheumatoid arthritis and cardiovascular disease.
    Ärlestig L; Rantapää-Dahlqvist S
    J Rheumatol; 2012 May; 39(5):939-45. PubMed ID: 22505696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum high sensitivity C-reactive protein and cognitive function in elderly women.
    Komulainen P; Lakka TA; Kivipelto M; Hassinen M; Penttilä IM; Helkala EL; Gylling H; Nissinen A; Rauramaa R
    Age Ageing; 2007 Jul; 36(4):443-8. PubMed ID: 17537742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study.
    Trollor JN; Smith E; Agars E; Kuan SA; Baune BT; Campbell L; Samaras K; Crawford J; Lux O; Kochan NA; Brodaty H; Sachdev P
    Age (Dordr); 2012 Oct; 34(5):1295-308. PubMed ID: 21853262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-specific associations between lipids and cognitive decline in the elderly.
    Ancelin ML; Ripoche E; Dupuy AM; Samieri C; Rouaud O; Berr C; Carrière I; Ritchie K
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1056-66. PubMed ID: 24721317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.